Skip to main content

Peer Review reports

From: Mirabegron for overactive bladder in frail patients 80 years or over (HOKUTO study)

Original Submission
31 Oct 2021 Submitted Original manuscript
8 Nov 2021 Author responded Author comments - Hiroshi Nakagomi
Resubmission - Version 2
8 Nov 2021 Submitted Manuscript version 2
11 Nov 2021 Author responded Author comments - Hiroshi Nakagomi
Resubmission - Version 3
11 Nov 2021 Submitted Manuscript version 3
16 Nov 2021 Reviewed Reviewer Report - Hamed Mohseni-Rad
17 Nov 2021 Reviewed Reviewer Report
21 Nov 2021 Reviewed Reviewer Report
17 Dec 2021 Author responded Author comments - Hiroshi Nakagomi
Resubmission - Version 4
17 Dec 2021 Submitted Manuscript version 4
17 Jan 2022 Reviewed Reviewer Report - Hamed Mohseni-Rad
24 Jan 2022 Reviewed Reviewer Report
1 Feb 2022 Reviewed Reviewer Report
15 Feb 2022 Author responded Author comments - Hiroshi Nakagomi
Resubmission - Version 5
15 Feb 2022 Submitted Manuscript version 5
9 Mar 2022 Author responded Author comments - Hiroshi Nakagomi
Resubmission - Version 6
9 Mar 2022 Submitted Manuscript version 6
Publishing
10 Mar 2022 Editorially accepted
21 Mar 2022 Article published 10.1186/s12894-022-00989-7

You can find further information about peer review here.

Back to article page